- £3.42bn
- £4.40bn
- $3.16bn
- 75
- 65
- 48
- 72
REG - Hikma Pharmaceutical - Final Results <Origin Href="QuoteRef">HIK.L</Origin> - Part 3
AnnouncementREG - Hikma Pharmaceutical - Final Results <Origin Href="QuoteRef">HIK.L</Origin> - Part 2
AnnouncementREG - Hikma Pharmaceutical - Final Results <Origin Href="QuoteRef">HIK.L</Origin> - Part 1
AnnouncementREG - Hikma Pharmaceutical - Notice of Results <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Roxane Acquisition Close <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Directorate Change <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - EGM Statement <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Circ re. Roxane Acquisition <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementRCS - Hikma Pharmaceutical - Hikma Analyst and Investor Call <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Circ re. Roxane Acquisition <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Circ re. Roxane Acquisition and EGM <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Shareholders' Agreement and Board Appointment <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights <Origin Href="QuoteRef">HIK.L</Origin>
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>
Announcement